1 Wall Street Analyst Believes Palantir Will More Than Double in a Year. Is She Right?

Palantir (PLTR) is down ~30% YTD and ~8% over the past 12 months, despite Q1 revenue growth spiking 85% YoY. Wall Street expects a step-down in growth (80% next quarter, 72% for 2026; 45% in 2027) and the stock trades at ~85x forward earnings vs ~20–30x for many large-cap peers, implying substantial growth is already priced in. Bank of America sets a $255 one-year target (vs ~$126 currently), but the article argues expectations may realign with slower growth, keeping downside risk elevated.

Analysis

This is less a fundamental deterioration story than a multiple-clearing event. When a stock is already capitalized for several years of near-perfect execution, the market stops rewarding topline outperformance and starts demanding evidence that the next leg of growth is both durable and monetizable; that makes any deceleration in growth rate disproportionately painful. In that regime, PLTR behaves more like a long-duration asset than a software compounder, so the main risk is not missing a quarter — it is a steady compression from peak narrative to a more ordinary software multiple.

Second-order, the pressure is likely to spill into adjacent high-valuation AI software names rather than into AI hardware. If investors re-rate PLTR lower, they may rotate toward names where current revenue base, enterprise stickiness, or cash flow conversion are easier to underwrite, which could support relative performance in lower-multiple software and infrastructure beneficiaries. The bigger loser is the basket of companies trading on optionality rather than visible earnings power; a PLTR de-rating can become a template for shaving premium across the AI software complex.

Catalyst-wise, the near-term risk is sentiment and positioning rather than a single data point: any modest guide or analyst target reset can accelerate a move because valuation has little cushion. Over 1-3 months, the key test is whether forward growth expectations hold near the high-60s/70s; if they slip or the market starts marking 2027 down, the stock can reprice much further than a normal earnings miss would imply. The contrarian case is that if commercial adoption and margin expansion stay unusually strong, the stock can remain expensive longer than skeptics expect — but that requires continued upward revision, not just a good quarter.

Key Decisions for Investors

• Short PLTR on strength or via 3-6 month put spreads; target a de-rating toward a mid-range software multiple, with downside accelerating if forward growth guidance slips below the low-70% area.
• Pair trade: long a lower-multiple AI software name or basket (e.g., SNOW/MDB) vs short PLTR for 1-3 months; thesis is valuation normalization within AI software, not an AI spend short.
• If already long PLTR, tighten risk into the next earnings/guidance window; the thesis is falsified if management sustains >75% forward revenue growth and raises 2026/2027 expectations enough to offset multiple compression.